Skip to main content

Table 4 Logistic multivariable analysis for poor adherence to weekly low-dose cisplatin

From: Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study

 

aOR

95% CI

P

Gender

 Male

Reference

  

 Female

0.92

0.25–3.16

0.9

Smoker

 Never

Reference

  

 Former

1.70

0.59–5.17

0.34

 Current

3.25

0.81–14.09

0.1

Age

 < 65

Reference

  

 65 or older

1.27

0.53–3.07

0.59

KPS

 90–100

Reference

  

 < 90

2.67

1.10–6.65

0.03

Race

 White

Reference

  

 Other

3.09

0.92–11.56

0.08

BMI

 Normal

Reference

  

 Underweight

6.89

0.43–218

0.2

 Overweight

1.7

0.58–5.23

0.34

 Obese

1.7

0.49–6.25

0.41

 Not available

 < 0.001

NA-1.63e122

0.99

Site

 Oropharynx

Reference

  

 Larynx

1.63

0.48–5.61

0.43

 Oral cavity

2.04e7

 < 0.001-NA

0.99

 Other

1.09

0.32–3.61

0.88

T staging

 1–2

Reference

  

 3–4

1.22

0.48–3.06

0.67

N staging

 0–1

Reference

  

 2–3

0.72

0.22–2.34

0.58

HPV

 Negative

Reference

  

 Positive

1.88

0.48–8.19

0.38

 Not available

1.01

0.30–3.56

0.98

  1. aOR Adjusted odds ratio, 95% CI 95% Confidence interval, BMI Body mass index, KPS Karnofsky performance status, HPV Human papillomavirus